Sun Pharmaceutical Industries and Moebius Medical, based in Israel, announced that two articles highlighting MM-II, a novel non-opioid product for the treatment of symptomatic knee osteoarthritis, were published in Osteoarthritis and Cartilage
The central government is pushing to mainstream swap kidney transplants through a unified national programme—a move experts believe could increase kidney transplant volumes by up to 15%. Swap transplants, or paired kidney exchanges, allow organ shari
 (1).png)
A pioneer in diagnostic medicine, Dr. Lal PathLabs Limited (Dr. Lal PathLabs) has unveiled Amyloid Typing by Laser Capture Microdissection & Mass Spectrometry, a ground-breaking test for precisely identifying various forms of amyloid....
A major industry shift occurs in India because the country faces growing advancements in preventable eye diseases. TeleMedC has announced its entry into the Indian market through a strategic business agreement with AND Healthcare Solutions, which ope
Natco Pharma announced that its generic Risdiplam will launch at Rs 15,900 per bottle, which might be a transformative moment for treating rare diseases in India. Roche's Evrysdi, marketed for spinal muscular atrophy (SMA) treatment, reaches Rs. 6.2
In a rapidly evolving Indian Pharmaceutical market, the growing demand for Obesity and diabetes drugs market is witnessing a huge heap through the continuous innovations by the leading companies. Notably, Danish pharm firm Novo Nordisk has announced
In a significant initiative for drug safety and regulatory efficiency, the Gujarat Food and Drug Control Administration (FDCA) will procure...
Akums Drugs & Pharmaceuticals Ltd., India's leading contract development and manufacturing organization (CDMO), has announced the launch of a pioneering Ripasudil-Timolol combination therapy for glaucoma treatment.
Multinational company Anteris Technologies Global Corp, is a head in Structural heart solutions, and it has reached an essential achievement with its DurAVR Transcatheter Heart valve(THV). Over 100 patients suffering from severe aortic stenosis
Sun Pharma Advanced Research business Ltd (SPARC), a biopharmaceutical business in the clinical stage, said that it has submitted an Investigational New Drug (IND) application to the FDA in the United States.
, CDSCO.jpg)
